New Jersey A 1439: Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2024-01-09)

State: New Jersey · Session: 221 · Bill: A 1439

Subjects: CONSUMER PRO, DISEASE, HEALTH INSUR, PHARMACEUTIC

Sponsors: Calabrese, Clinton, Karabinchak, Robert J., Quijano, Annette, DeAngelo, Wayne P., Freiman, Roy, Reynolds-Jackson, Verlina, Stanley, Sterley S.

View New Jersey A 1439 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.